Document:

Exhibit
4.1

 

DESCRIPTION
OF THE REGISTRANT’S SECURITIES

REGISTERED
PURSUANT TO SECTION 12 OF THE

SECURITIES
EXCHANGE ACT OF 1934

 

﻿OptimizeRx
Corporation has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended:
our common stock, par value $.001 per share (the “common stock”). References herein
to “we,” “us” and “our company” refer to OptimizeRx Corporation  and
not to any of our subsidiaries.

﻿

DESCRIPTION
OF COMMON STOCK

﻿

The following description of the common stock of OptimizeRx
Corporation  is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference
to our articles of incorporation and bylaws, each of which is incorporated by reference
as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part. We encourage
you to read our articles of incorporation, bylaws and the applicable provisions of the Nevada
Revised Statutes (“NRS”) for additional information.

 

Description of Common Stock

 

Authorized Capitalization

 

Our articles of incorporation
provide for authorized capital stock of 166,666,667 shares of common stock, par value $0.001 per share, and 10,000,000 shares of undesignated
preferred stock, par value $0.001 per share. The rights, preferences and privileges of the holders of common stock are subject to, and
may be adversely affected by, the rights of the holders of shares of any then outstanding preferred stock. As of the date hereof, no shares
of preferred stock are outstanding. Our board of directors, subject to the provisions of our articles of incorporation and limitations
imposed by law, has the authority to designate, from time to time and without stockholder approval, preferred stock in one or more series,
and to prescribe with respect to each such series the voting powers, if any, designations, preferences, and relative, participating, optional,
or other special rights, and the qualifications, limitations, or restrictions relating to such series.

 

Dividend Rights

 

Subject to preferences
that may apply to shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends
out of assets legally available at the times and in the amounts as our board may from time to time determine.

 

Voting Rights

 

Each holder of record
of our common stock is entitled to one vote for each share of our common stock held on all matters submitted to a vote of the stockholders.
If a quorum is present, unless our articles of incorporation, our bylaws, the rules or regulations of any stock exchange applicable to
us, or applicable law provide for a different proportion, action by the stockholders entitled to vote on a matter, other than the election
of directors, is approved by and is the act of the stockholders if the number of votes cast in favor of the action exceeds the number
of votes cast in opposition to the action. If a quorum is present, unless otherwise provided by our articles of incorporation or bylaws,
directors shall be elected by a plurality of the votes cast.

 

No Preemptive or Other Rights

 

Holders of our common
stock are not entitled to preemptive, subscription, cumulative voting or conversion rights and there are no redemption or sinking fund
provisions applicable to our common stock.

 

     

     

    

 

Right to Receive Liquidation
Distributions

 

In the event of our liquidation,
dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets remaining after payments to creditors
and after satisfaction of the liquidation preference, if any, of the holders of any preferred stock that may at the time be outstanding.

 

Certain Anti-Takeover Effects
of our Articles of Incorporation and Bylaws and Nevada Law

 

Certain provisions of
our articles of incorporation and bylaws, and certain provisions of the NRS may have an effect of delaying, deferring or preventing a
change in control of the Company.

 

Undesignated Preferred
Stock. Our board of directors is authorized to approve the issuance of preferred stock without stockholder approval and to determine
the number of shares, the designations and the relative preferences, rights, restrictions and qualifications of any series of preferred
stock. As a result, our board of directors could, without stockholder approval, authorize the issuance of preferred stock with voting,
dividend, redemption, liquidation, sinking fund, conversion and other rights that could proportionately reduce, minimize or otherwise
adversely affect the voting power and other rights of holders of the Company’s capital stock or that could have the effect of delaying,
deferring or preventing a change in control.

 

No Stockholder Action
by Written Consent. Our bylaws prohibit stockholders from acting by written consent. Accordingly, stockholder action must take
place at an annual or a special meeting of the Company’s stockholders.

  

Board Vacancies. 
Subject to any rights of the holders of preferred stock, if any, vacancies on our board of directors, howsoever resulting, may be filled
only by a majority of the remaining directors, even if less than a quorum, or by a sole remaining director. Any director elected to fill
a vacancy shall hold office for a term expiring at the next annual meeting of stockholders and until such director’s successor is
duly elected and qualified.

 

Removal of Directors. Our
bylaws provide that, subject to any rights of the holders of preferred stock, if any, and except as otherwise provided in the NRS, any
director, or the entire Board, may be removed from office by the affirmative vote of the holders of not less than two-thirds of the voting
power of the issued and outstanding stock entitled to vote at an annual or special meeting of the stockholders duly noticed and called
in accordance with our bylaws. NRS 78.335 generally requires the vote of stockholders representing not less than two-thirds of the voting
power of the issued and outstanding stock entitled to vote in order to remove an incumbent director.

 

 Advance Notice
Requirements.  Stockholders wishing to nominate persons for election to our board of directors at an annual meeting or to
propose any business to be considered by our stockholders at an annual or special meeting must comply with certain advance notice and
other requirements set forth in our bylaws. Likewise, if our board of directors has determined that directors shall be elected at a special
meeting of stockholders, stockholders wishing to nominate persons for election to our board of directors at such special meeting must
comply with certain advance notice and other requirements set forth in our bylaws.

 

Nevada Anti-Takeover
Statutes. Nevada’s “acquisition of controlling interest” statutes (NRS 78.378 through 78.3793, inclusive) contain
provisions governing the acquisition of a controlling interest in certain Nevada corporations. These “control share” laws
provide generally that any person that acquires a “controlling interest” in certain Nevada corporations may be denied voting
rights, unless a majority of the disinterested stockholders of the corporation elects to restore such voting rights. These laws would
apply to us as of a particular date if we were to have 200 or more stockholders of record (at least 100 of whom have addresses in Nevada
appearing on our stock ledger at all times during the 90 days immediately preceding that date) and do business in the State of Nevada
directly or through an affiliated corporation, unless our articles of incorporation or bylaws in effect on the tenth day after the acquisition
of a controlling interest provide otherwise. These laws provide that a person acquires a “controlling interest” whenever a
person acquires shares of a subject corporation that, but for the application of these provisions of the NRS, would enable that person
to exercise (1) one-fifth or more, but less than one-third, (2) one-third or more, but less than a majority or (3) a majority or more,
of all of the voting power of the corporation in the election of directors. Once an acquirer crosses one of these thresholds, shares which
it acquired in the transaction taking it over the threshold and within the 90 days immediately preceding the date when the acquiring person
acquired or offered to acquire a controlling interest become “control shares” to which the voting restrictions described above
apply. 

 

    2

     

    

 

Nevada’s “combinations
with interested stockholders” statutes (NRS 78.411 through 78.444, inclusive) provide that specified types of business “combinations”
between certain Nevada corporations and any person deemed to be an “interested stockholder” of the corporation are prohibited
for two years after such person first becomes an “interested stockholder” unless the corporation’s board of directors
approves the combination (or the transaction by which such person becomes an “interested stockholder”) in advance, or unless
the combination is approved by the board of directors and at least sixty percent of the corporation’s voting power not beneficially
owned by the interested stockholder, its affiliates and associates. Furthermore, in the absence of prior approval certain restrictions
may apply even after such two-year period. For purposes of these statutes, an “interested stockholder” is any person who is
(1) the beneficial owner, directly or indirectly, of 10% or more of the voting power of the outstanding voting shares of the corporation,
or (2) an affiliate or associate of the corporation and at any time within the two previous years was the beneficial owner, directly or
indirectly, of 10% or more of the voting power of the then-outstanding shares of the corporation. The definition of the term “combination”
is sufficiently broad to cover most significant transactions between a corporation and an “interested stockholder.” These
laws generally apply to Nevada corporations with 200 or more stockholders of record.

 

In addition, NRS 78.139
also provides that directors may resist a change or potential change in control of the corporation if the board of directors determines
that the change or potential change is opposed to or not in the best interest of the corporation upon consideration of any relevant facts,
circumstances, contingencies or constituencies pursuant to NRS 78.138(4).

 

 

3Document

NON-EMPLOYEE DIRECTOR
RESTRICTED STOCK UNIT AWARD
UNDER THE
2021 LINDE PLC
LONG TERM INCENTIVE PLAN

Effective as of INSERT DATE (the “Grant Date”), «Legal_First_Name» «MI» «MI1» «MI2» «Last_Name» (the “Participant”) is hereby granted the following Restricted Stock Unit (“RSU”) Award under the 2021 Linde plc Long Term Incentive Plan (the “Plan”), subject to the terms and conditions of the Plan, which are incorporated herein by reference, and those set forth below.  The Plan shall control in the event of any conflict between the terms and conditions of the Plan and those set forth in this Award. 

This Award has been conveyed and will be managed online, and the Participant’s online acceptance and acknowledgement of this Award constitutes his or her acceptance of all of the terms and conditions of the Plan and this Award. A copy of the Plan has been made available to the Participant, and the Participant hereby acknowledges that he or she has read and understands the Plan and this Award. Capitalized terms used herein and not defined shall have the meanings set forth in the Plan, as the same may be amended from time to time.  For purposes of this Award, Linde plc (the “Company”) and its Subsidiaries are collectively referred to herein as “Linde”.

1.Award of Restricted Stock Units.  The Participant is hereby granted an award of [INSERT#] notional RSUs (the “Award”).  Each RSU represents a bookkeeping entry which is intended to be equal in value to a single Share.

2.Vesting of Award.
a.Vesting.   Except as otherwise provided herein:

(i)This Award shall vest in full and become non-forfeitable on the first anniversary of the Grant Date if, and only if, the Participant has continuously served on the Board of Directors of the Company (the “Board”) at all times from the Grant Date through the first anniversary of the Grant Date. 
(ii)If the Participant’s service on the Board terminates for any reason other than because of removal by the Board for cause or by the shareholders prior to the first anniversary of the Grant Date, this Award shall immediately vest and become non-forfeitable as to a pro rata number of Shares based on the number of calendar days elapsed from the Grant Date through the date on which the Participant’s Board service terminated.
(iii)The termination of the Participant’s service on the Board because of removal by the Board for cause or by the shareholders prior to the first anniversary of the Grant Date shall result in a full and immediate forfeiture of the Award.

b.Change in Control.   Notwithstanding any provision of this Section 2 to the contrary, in the event of a Change in Control occurring prior to the vesting date, except to the extent that a Replacement Award meeting the requirements set forth below is provided to the Participant to replace this Award, this Award shall become immediately vested. 
(i)Except as otherwise provided herein, a “Replacement Award” means an award:  (a) having a value at least equal to the value of this Award as determined by the Committee in its sole discretion; (b) relating to publicly traded equity securities of the Company or its successor in the Change in Control or another entity that is affiliated with the Company or its successor following the Change in Control; (c) which shall also become fully vested upon the Participant’s termination of service as a Director occurring in connection with, or during the period immediately after, such Change in Control but before the vesting date; and (d) with such other terms and conditions that are not less favorable to the Participant than the terms and conditions of this Award. 
(ii)If, immediately following the occurrence of a Change in Control, Linde plc ordinary shares continue to be publicly traded, a Replacement Award may, in the sole discretion of the Committee, take the form of a continuation of this Award, subject to such adjustments as the Committee shall determine to be necessary to ensure that such Replacement Award remains no less favorable to the Participant than this Award.
(iii)The determination of whether the conditions of this Section 2.b. are satisfied shall be made by the Committee in its sole discretion. All references to the Committee in this Section 2.b. shall mean the Committee as constituted immediately before the Change in Control.

3.Payment of Vested Award; Treatment upon Change in Control.  

a.This Award shall be settled as soon as practicable following its vesting date (the “Settlement Date”). Settlement of the Award shall occur by payment to the Participant of a number of Shares equal to (i) the full number of RSUs granted under this Award if the Award has vested in full on the first anniversary of the Grant Date (plus any vested accrued Dividend Equivalents pursuant to Section 4.b.); or (ii) a pro rata number of RSUs granted under this Award if the Award has partially vested prior to the first anniversary of the Grant Date (plus any vested accrued Dividend Equivalents pursuant to Section 4.b.). Settlement of the Award in connection with a Change in Control may be such other form of payment having an equivalent value as may be authorized by the Committee in its sole discretion.

4.Other Terms and Conditions.  It is understood and agreed that the Award of RSUs evidenced hereby is subject to the following terms and conditions:

a.Rights of Participant.  Except as provided in Section 4.e., the Participant shall have no right to transfer, pledge, hypothecate or otherwise encumber the Award.  Prior to the payment of Shares in satisfaction of this Award, the Participant shall have none of the rights of a stockholder of the Company with respect to the Award, including, but not limited to, voting rights and the right to receive  dividends, subject to the accrual of dividend equivalents provided in Subsection (b) below.

b.Dividend Equivalents.  As of the date any dividend is paid to holders of Shares, the Award will be credited with additional RSUs equal to the number of Shares that could have been purchased with the amount which would have been paid as dividends on that number of Shares (including fractions of a share to three decimals) equal to the number of RSUs then subject to this Award as of the record date applicable to such dividend.  The number of additional RSUs to be credited will be calculated to three decimals by dividing the amount which would have been paid as dividends by the closing price of a Share as reported on the New York Stock Exchange as of the date the dividend would have been paid.  In the case of dividends paid in property other than cash, the amount of the dividend shall be deemed to be the fair market value of the property at the time of the payment of the dividend, as determined in good faith by the Committee.  Dividend Equivalents shall be settled in Shares on the Settlement Date, and any fractional amount shall be rounded down to the nearest whole share.

c.No Right to Continued Service as a Director.  This Award shall not confer upon the Participant any right with respect to continuance of service as a director of the Company, nor shall this Award interfere with the right of the Company’s Board of Directors or the shareholders to remove the Participant as a director, with or without cause. 

d.No Right to Future Awards.  The Participant’s selection to receive this Award shall in no way entitle him/her to receive, or otherwise obligate the Company or its Board of Directors to provide the Participant, any future RSUs or other awards under the Plan or otherwise.

e.Transferability.  This Award is not transferable other than:

(i)in the event of the Participant’s death, in which case this Award shall be transferred to the Participant’s executor, administrator, or legal representative, or
(ii)pursuant to a domestic relations order.

Any transfer of this Award, in whole or in part, is subject to acceptance by the Company in its sole discretion and shall be affected according to such procedures as the Governance Committee (or other designated committee) of the Board of Directors of the Company may establish.  The provisions of this Award, relating to the Participant, shall apply to this Award notwithstanding any transfer to a third party.

f.Cancellation of Award.  Notwithstanding any other provision of this Award, the Committee may, in its sole discretion, cancel, rescind, suspend, withhold, or otherwise limit or restrict this Award, and/or recover any gains realized by the Participant in connection with this Award, in the event any actions by the Participant are determined by the Committee to (i) constitute a conflict of interest with Linde, (ii) be prejudicial to Linde’s interests, or (iii) violate any non-compete agreement or obligation of the Participant to Linde, any confidentiality agreement or obligation of the Participant to Linde, or Linde’s applicable policies.

5.Tax Withholding.  Upon the Settlement Date, the Company may deduct from the number of Shares (or other form of payment if applicable) otherwise due the Participant, Shares (or other form of payment if applicable) having a Fair Market  Value  sufficient to discharge all applicable federal, state, city, local or foreign taxes of any kind, if any, required to be withheld with respect to such payment; provided that, if Shares are so withheld, they shall be withheld only up to the rate that will not trigger a negative accounting impact on the Company.  In the alternative, the Company shall have the right to require the 

Participant to pay cash to satisfy any applicable withholding taxes as a condition to the payment of the Award.

6.References.  References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant’s legal representative or estate without regard to whether specific reference to such legal representative or estate is contained in a particular provision of this Award.

7.Governing Law.  This Award shall be governed by and construed in accordance with the laws of Connecticut, without giving effect to principles of conflict of laws.

8.No Third Party Beneficiaries.  Except as expressly provided in the Plan or herein, neither the Plan nor this Award will confer on any person other than Linde and the Participant any rights or remedies under the Plan or hereunder.

IN WITNESS WHEREOF, the Company has caused this instrument to be executed by its proper officer hereunto duly authorized, as of the day and year first hereinabove written.

                    Linde plc               

                                      
  
By:_________________

 Guillermo Bichara     
 General Counsel

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]